Vancomycin-resistant enterococci colonization in patients at seven hemodialysis centers

Kidney International

Volumn 60, Issue 4, 2001, Pages 1511-1516

  Tokars, Jerome I ^a,b,c,d,e   Gehr, Todd ^a,b,c,d,e   Jarvis, William R ^a,b,c,d,e   Anderson, John ^a,b,c,d,e   Armistead, Nancy ^a,b,c,d,e   Miller, Elaine R ^a,b,c,d,e   Parrish, Joan ^a,b,c,d,e   Qaiyumi, Sadaf ^a,b,c,d,e   Arduino, Matthew ^a,b,c,d,e   Holt, Stacey C ^a,b,c,d,e   Tenover, Fred C ^a,b,c,d,e   Westbrook, Glennis ^a,b,c,d,e   Light, Paul ^a,b,c,d,e  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^d Mid Atlantic Renal Coalition   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial infection; Chronic hemodialysis; Epidemic; ESRD; Infection control; Pathogen; Transmission of VRE

Indexed keywords

ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG USE; ENTEROCOCCUS; FECES CULTURE; FEMALE; HEMODIALYSIS; HUMAN; INFECTION CONTROL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHYSICAL ACTIVITY; PHYSICAL DISABILITY; PREVALENCE; PRIORITY JOURNAL; RECTUM; RISK FACTOR;

EID: 0034786036     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.00955.x     Document Type: Article

References (38)

1. Antimicrobial resistance in intensive care units
2. Antimicrobial resistance
3. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit
4. Enterococci resistant to multiple antibiotic agents, including vancomycin
5. Bloodstream infections with vancomycin-resistant enterococci
6. High-level vancomycin-resistant enterococci causing hospital infections
7. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections
8. Risk factors for acquisition of vancomycin-resistant enterococci among patients on a renal ward during a community hospital outbreak
9. National surveillance of dialysis-associated diseases in the United States, 1997
10. Emergence of vancomycin resistance in Staphylococcus aureus
11. Staphylococcus aureus with reduced susceptibility to vancomycin - Illinois, 1999
12. Vancomycin-intermediate and -resistant Staphyloccus aureus: What the infectious disease specialist needs to know
13. Performance status assessment among oncology patients: A review
14. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
15. General linear models for longitudinal data
16. Colonization with vancomycin-resistant enterococci in chronic hemodialysis patients
17. Vancomycin-resistant enterococci in hemodialysis patients is related to intravenous vancomycin use
18. Vancomycin-resistant enterococci among chronic hemodialysis patients: A prospective study of acquisition
19. Outpatient vancomycin use and vancomycin-resistant enterococcal colonization in maintenance dialysis patients
20. Comparison of direct plating and broth enrichment culture for the detection of intestinal colonization by glycopeptide-resistant enterococci among hospitalized patients
21. Prevalence and molecular epidemiology of glycopeptide-resistant enterococci in Belgian renal dialysis units
22. Vancomycin-resistant enterococcus in end-stage renal disease
23. The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans' Affairs institution
24. Vancomycin-resistant enterocccal infections
25. Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection
26. Hospital infection control practices advisory committee: Guideline for isolation precautions in hospitals
27. Nosocomial infections associated with hemodialysis
28. Recommendations for preventing transmission of infections among chronic hemodialysis patients
29. The hospital infection control practices advisory oommittee: Guideline for prevention of intravascular devicerelated infections
30. Dialysis outcomes quality initiative: Clinical practice guidelines
31. Recommendations for preventing the spread of vancomycin resistance
32. Use of cefazolin in chronic hemodialysis patients: A safe and effective alternative to vancomycin
33. Cefazolin as empiric therapy in hemodialysis-related infections: Efficacy and blood concentrations
34. Vancomycin use in a university medical center: Effect of a vancomycin continuation form
35. Excessive use of vancomycin: A successful intervention strategy at an academic medical center